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Abstract The microenvironment is being increasingly
recognized as a critical component in tumor progression
and metastases. As such, the bi-directional signaling of
extracellular mediators that promote tumor growth within
the microenvironment is a focus of intense scrutiny.
Interestingly, there are striking similarities between the
phenotypes of aggressive tumor and embryonic stem cells,
particularly with respect to specific signaling pathways
underlying their intriguing plasticity. Here, we demonstrate
the epigenetic influence of the hESC microenvironment on
the reprogramming of aggressive melanoma cells using an
innovative 3-D model. Specifically, our laboratory has
previously demonstrated the redifferentiation of these
melanoma cells to a more melanocyte-like phenotype
(Postovit et al., Stem Cells 24(3):501–505, 2006), and
now we show the loss of VE-Cadherin expression (indic-
ative of a plastic vasculogenic phenotype) and the loss of
Nodal expression (a plasticity stem cell marker) in tumor
cells exposed to the hESC microenvironment. Further
studies with the 3-D culture model revealed the epigenetic
influence of aggressive melanoma cells on hESCs resulting
in the down-regulation of plasticity markers and the
emergence of phenotype-specific genes. Additional studies
with the aggressive melanoma conditioned matrix microen-
vironment demonstrated the transdifferentiation of normal
melanocytes into melanoma-like cells exhibiting a vasculo-
genic phenotype. Collectively, these studies have advanced
our understanding of the epigenetic influence associated
with the microenvironments of hESCs and aggressive
melanoma cells, and shed new light on their therapeutic
implications. Moreover, we have a better appreciation of the
convergence of embryonic and tumorigenic signaling path-
Cancer Microenvironment (2008) 1:13–21
DOI 10.1007/s12307-008-0004-5
Daniel E. Abbott, Caleb M. Bailey, Lynne-Marie Postovit, Elisabeth
A. Seftor contributed equally.
D. E. Abbott
Children’s Memorial Research Center, Department of Surgery,
Northwestern University/Feinberg School of Medicine,
Chicago, IL 60614, USA
C. M. Bailey: E. A. Seftor: N. Margaryan
Cancer Biology and Epigenomics Program,
Children’s Memorial Research Center,
Chicago, IL 60614, USA
L.-M. Postovit
Department of Anatomy and Cell Biology,
Schulich School of Medicine and Dentistry,
University of Western Ontario,
Medical Sciences Building, Rm. 438,
London, ON N6A 5C1, Canada
R. E. B. Seftor:M. J. C. Hendrix (*)
Cancer Biology and Epigenomics Program,
Children’s Memorial Research Center,
Robert H. Lurie Comprehensive Cancer Center,
Northwestern University/Feinberg School of Medicine,
2430 North Halsted Street, P.O. Box 222,
Chicago, IL 60614, USA
e-mail: mjchendrix@childrensmemorial.orgways that might stimulate further consideration of targeting
Nodal in aggressive tumor cells resulting in a down-
regulation of tumorigenic potential and plasticity.
Keywords Embryonicstemcells.Microenvironment.
Epigenetic.Nodal.Melanoma
Introduction
Recent attention has been given to comparisons between
stem cells and aggressive cancer cells. Indeed, similarities
such as unlimited proliferative potential, cellular plasticity,
and the expression of genes involved in maintaining
pluripotency and/or plasticity are shared by these two
different cell types (Table 1)[ 2, 3]. Specifically, recent
studies have revealed a convergence of critical pathways
associated with both cancer progression and normal
embryologic development including Hedgehog, Wingless
(Wnt), Notch and Nodal signaling pathways [4–7]. The
identification of these shared pathways has led to a more
comprehensive examination of the bi-directional micro-
environmental communication propagated among cells
through at least three different mechanisms: direct cell–cell
contact, autocrine and paracrine signaling driven by soluble
secreted factors, and modeling (or re-modeling) of the
extracellular matrix. Each mechanism plays an important
role in both normal developmental pathways and malignant
cancer development and progression.
The microenvironment can exert profound epigenetic
effects on cells through interactions between cells, or
through cell-derived factors deposited into the microenvi-
ronment. These effects can be transient, as seen with
signaling pathways regulating cellular proliferation and
migration, or associated with more stable events, such as
cell fate determination and differentiation. While normal
development in the embryo is coordinated by a complex
equilibrium between positively and negatively acting cues
and signals, our work and that of others have demonstrated
an aberrant expression of potent, embryonic morphogens
by some aggressive cancer cell types which, in the absence
of their normal negative regulators, induce uncontrolled
proliferation, increased survival, dedifferentiation and plas-
ticity in these specific cancer cells [5, 8, 9]. This combina-
tion of increased survival and plasticity promotes malignant
transformation and contributes to metastasis.
Given the critical role of the microenvironment in
cellular regulation and the observation that gene expression
profiles and certain phenotypic characteristics are shared by
human embryonic stem cells (hESCs) and some aggressive
melanoma cells, we examined potential similarities and dif-
ferences between the epigenetic influence of microenviron-
ments associated with hESCs and aggressive melanoma
cells. Since the embryonic microenvironment possesses key
regulatory cues and signaling molecules that function to
maintain and regulate the growth of the stem cell popula-
tion, we hypothesized that an embryonic microenvironment
might be able to influence cancer cells by normalizing their
plastic phenotype. The concept that an embryonic micro-
environment could reprogram cancer cells was elegantly
highlighted by studies in the early 1970s by Mintz and
Illmensee who reported that teratocarcinoma cells injected
into murine blastocysts demonstrated totipotency and a
reversion to a normal phenotype [10, 11]. This model
firmly established a non-mutational basis for the transfor-
mation of these teratocarcinoma cells to a malignant
phenotype, and demonstrated the unique ability of an
embryonic microenvironment to reprogram these cells to a
normal phenotype. These studies were corroborated in an
avian model during the 1980s by Dolberg and Bissell who
showed that Rous sarcoma virus injected in the chick
embryo would not induce sarcoma formation [12]. Our
laboratory and others recently extended these studies and
demonstrated that the chick and zebrafish embryonic
microenvironments (approximately six to eight somite stage
in chick development and blastula stage in zebrafish) not
only repress tumor formation when implanted with aggres-
sive human melanoma cells, but induce lineage-specific
genes and migratory behaviors associated with a more
normal phenotype—representative of an epigenetic repro-
gramming event [13, 14]. Additional studies by Haldi and
coworkers demonstrated that metastatic melanoma cells
implanted in the zebrafish microenvironment 2 days post-
fertilization retained their enhanced proliferative, migratory
and tumorigenic characteristics [15]. These observations
leant further support to the concept that the early-stage
embryonic microenvironment is unique and specific to
events associated with the ability to reprogram aggressive
melanoma cells.
While these seminal studies demonstrated that the
embryonic microenvironment could have significant influ-
Table 1 A comparison of select embryonic markers expressed in
human embryonic stem cells vs. aggressive melanoma cells
Gene expression
Gene name Human embryonic
stem cells (H9)
Aggressive melanoma
cells (C8161)
Nodal +++ ++
Lefty +++ −
Cripto +++ +/−
Oct3/4 ++ −
Nanog ++ −
Relative gene expression by real time PCR analysis of select cell types
designated by: +++ significant expression; ++ moderate expression; +
expression by a subpopulation of cells; and − no expression.
14 D.E. Abbott, et al.ence on the phenotypic characteristics of aggressive cancer
cells, the converse—an evaluation of the effects of a tumori-
genic microenvironment on embryonic stem cells—has not
been sufficiently explored. Recent studies by Karnoub and
colleagues have revealed key signaling pathways between
bone marrow-derived mesenchymal stem cells and human
breast cancer cells, and sought to identify the relationship
between the tumorigenic microenvironment and tissue-
specific stem cell populations [16]. In light of the observa-
tion that there are unique phenotypic characteristics shared
by both embryonic stem cells and aggressive melanoma cells
which may be profoundly influenced by the embryonic
microenvironment, we examined the ability of their respec-
tive microenvironments to affect and/or influence the pheno-
type of the other. In this review, we present an evaluation of
recent data illuminating the effects of the hESC-conditioned
matrix microenvironment on aggressive C8161 melanoma
cells as well as novel and dramatic findings concerning the
effects of the C8161 melanoma-conditioned matrix micro-
environment on hESCs. These observations may lead to the
development of novel cancer therapeutics based on targeting
converging pathways leading to a reversal of the dediffer-
entiated, plastic tumor cell phenotype.
Embryonic Microenvironment
The embryonic microenvironment is a dynamic yet finely
regulated network of cellular communication that is critical to
cell behavior and fate determination throughout embryogenesis
and beyond. Molecular cues in the embryonic milieu,
originating from a variety of cell types, possess various
signaling characteristics with diverse effects on specific target
cells or tissues. Certain stimulatory factors such as Activin,
Nodal and FGF maintain pluripotency in embryonic stem cells,
while other factors, such as ngn3, Notch, and ASK-1
(endocrine, hematopoietic, and neuronal lineages, respective-
ly), dictate a differentiated fate [17–20]. These signals regulate
the phenotype of stem cells or their progeny and are at times
antagonistic, and may be separated in a spatial and/or
temporal fashion. These processes are exquisitely complex,
and their sophistication continues to be appreciated as
molecular profiling of embryonic stem cells and their
microenvironment(s) is continually studied and analyzed
[21–23]. However, despite an incomplete understanding of
the full scope of microenvironmental contributions to organ-
ism development, health, and disease, exciting insights into
the influence of embryonic stem cells and their regulatory
properties have been made. These breakthroughs in embry-
onic stem cell biology offer tremendous promise in numerous
therapeutic arenas, most notably regenerative technologies
and oncologic therapy. It is through further investigation into
this genre that such breakthroughs will be realized.
The complexity of the embryonic microenvironment is
determined by a number of factors. Perhaps most important
is the cellular composition which dictates the temporal and
spatial distribution of signaling molecules which then direct
cell fate determination, embryogenesis and appropriate
apoptotic cues [24, 25]. These factors orchestrate elegant
developmental steps in a regulated fashion, with the
inhibitory signaling molecules among the most important
factors within the embryonic milieu, as they regulate appro-
priate growth and differentiation while limiting unabated
development [26–28]. For example, Lefty is a stem-cell
derived inhibitor of the Activin-Nodal signaling pathway
that promotes differentiation of stem cells and may play an
important role in normal gastrulation and neural tube
formation [29–31]. This regulation is critical and will be
discussed later, specifically with respect to tumorigenesis.
Based on the concept that the hESC microenvironment
provides a dynamic regulatory niche for stem cell function,
we explored the possibility that this embryonic microenvi-
ronment could reprogram the plastic tumor cell phenotype.
To address the need for a novel experimental design that
expands on standard cellular gene and protein expression
analysis, our laboratory has developed an in vitro model
that employs a 3-D matrix (Fig. 1) to assess micro-
environmental properties and influences when conditioned
by specific cells types, primarily hESCs (aggressive cancer
cells may also be used—to be discussed in more detail
later). Briefly, cells are plated on a 3-D matrix for 3–4 days
followed by lysis and removal using a dilute concentration
Fig. 1 3-D model to study the epigenetic influence of the microenvi-
ronment on cell phenotype. Compact colonies of human embryonic
stem cells (hESCs) or cancer cells are seeded onto a 3-D matrix
(composed of Matrigel or type I collagen) for 3 to 4 days, then
removed, resulting in a conditioned 3-D matrix (CMTX) onto which
other cell types (such as hESCs, cancer cells, or normal melanocytes)
are seeded and incubated for 3–4 days. Subsequently, changes in cell
morphology, gene and protein expression as well as behavioral
function(s) of the cells can be examined
Tumor and Embryonic Microenvironments 15of ammonium hydroxide. Cells of interest are subsequently
re-plated on this conditioned matrix (CMTX). Following
3–4 days of growth on the conditioned matrix, cells are
removed for morphological, proliferative, functional, RNA
or protein analysis. This approach permits a comprehensive
analysis of the myriad influences a conditioned microenvi-
ronment may exert on neighboring cells, and provides a
foundation from which further work may be designed and
undertaken.
Both hESCs and certain aggressive cancer cells have the
ability to affect/alter their respective microenvironments to
induce epigenetic effects on subsequent cell populations
when placed into these conditioned microenvironments. In
particular, an extracellular matrix conditioned by hESCs
results in dramatic changes in cells introduced into this
environment. Figure 2a reveals the profound morphological
changes that aggressive melanoma cells (C8161) display
following culture on an hESC CMTX. Compared to con-
trols (C8161 cells grown on an unconditioned control
matrix; top panel), where melanoma cells grow primarily in
an over-confluent monolayer, these same cells form
spheroidal clusters in a manner similar to the morphology
characteristic of stem cells cultured on an hESC CMTX
(bottom panel).
The epigenetic nature of this transformation is especially
evident after the melanoma cells are removed from the
hESC CMTX and cultured under normal (non-embryonic)
conditions. After removal from the influence of the hESC
CMTX, the melanoma cells revert to their original mor-
phologic appearance by 7 days. Figure 2b depicts a 2-week
time-course during which C8161 cells are cultured on an
hESC CMTX for 3 days and removed. Each panel shows
the morphological changes associated with reversion back
to an aggressive phenotype as more time elapses post-
exposure to an hESC CMTX. At 2 days, just as in Fig. 2a
(lower panel), aggressive melanoma cells appear as sphe-
roidal clusters, reminiscent of hESC colonies. By day 4
(panel b; post-removal from an hESC CMTX and re-plating
on a control matrix), this spheroid morphology begins to
diminish while at day 7, the vasculogenic phenotype asso-
ciated with aggressive melanoma cells is quite evident
and any similarity to the embryoid body morphology of an
ES cell cluster has diminished significantly. Two weeks
following removal from an hESC CMTX, the aggressive
C8161 cells have lost all semblance of an hESC cluster and
appear identical to control melanoma cells that had never
been exposed to an hESC CMTX. Such dramatic pheno-
typic changes demonstrate the profound influence of an
embryonic conditioned microenvironment on aggressive
tumor cells—during the time of exposure—and also high-
light the transient nature of the epigenetic event.
Coincident with this morphologic transformation is an
alteration in protein expression which is also induced by the
hESC CMTX. For example, VE-Cadherin (an endothelial
cell-associated gene product associated with vasculogenic
mimicry in malignancy) is expressed in abundance by
aggressive melanoma cells [32, 33]. When aggressive
melanoma cells are exposed to an hESC CMTX, VE-
Cadherin expression is significantly down-regulated with
the greatest response seen at 4 days after removal of
melanoma cells from the conditioned microenvironment
(Fig. 2c). By day 14 post-removal from the hESC CMTX,
the cells express levels of VE-Cadherin equivalent to the
control (untreated) cells within the same period of time
concurrent with their morphological reversion to their
original phenotype. These data corroborate past findings
in our laboratory which showed that melanoma cells
exposed to an hESC CMTX underwent a 32% increase in
methylation within a putative transcription factor binding
Fig. 2 The microenvironment of hESCs epigenetically inhibits the
vasculogenic phenotype of aggressive melanoma cells. a Phase-
contrast microscopy of C8161 metastatic melanoma cells grown on a
control Matrigel matrix (upper panel) and induced to form spheroids
(a marked morphological alteration resembling hESC colonies)
following exposure to a 3-D hESC microenvironment (hESC CMTX;
lower panel). b This induction of spheroid formation is reversible as
C8161 melanoma cells exposed to control Matrigel matrix following
exposure to hESC CMTX are able to resume their plastic phenotype
and form vasculogenic-like networks following a 7-day recovery
period. c Western blot analysis of VE-Cadherin protein in C8161 cells
exposed for 3 days to either control (unconditioned) Matrigel or to
Matrigel conditioned by hESCs (hESC CMTX). Some cancer cells
exposed to the hESC CMTX were subsequently recovered on control
(unconditioned) Matrigel for 2 to 14 days prior to Western blot
analysis. Actin is used as a loading control
16 D.E. Abbott, et al.site of the Nodal gene, as well as a substantial increase in
melan-Aproduction,exhibitingamore melanocytic(benign)
phenotype [1, 34]. This demonstration of epigenetic modu-
lation by an embryonic microenvironment illustrates the
extraordinary influence that the microenvironment can
have on cellular architecture, behavior and gene expression.
These findings underscore the possibility of defining factor
(s) within the hESC microenvironment that might down-
regulate the plasticity of aggressive melanoma cells, as
demonstrated in Fig. 2.
Cancer Microenvironment
An impressive body of work has been performed in
assessing the effects of cancer cells and their influence on
the microenvironment. Through specific signaling mole-
cules and re-modeling of their extracellular milieu (both
cellular and stromal), aggressive cancer cells (or perhaps
particular cancer stem cells) have the ability to enhance
their tumorigenicity in functioning as a dynamic entity
within their surroundings [35]. Our laboratory, and others,
have highlighted key features of the extracellular space that
play such a critical role in tumor remodeling, including
laminin-5γ2, matrix metalloproteinases and other basement
membrane constituents [36, 37]. The importance of the
tumor microenvironment has been realized from a thera-
peutic perspective as well, in that a number of treatments
that target the extracellular components of tumors are in
development or clinical trials [38, 39].
An example of how aggressive cancer cells (with an
embryonic-like phenotype) may also affect their micro-
environment to induce phenotypic changes in other cells is
illustrated by culturing normal human melanocytes (which
exhibit a homogeneously benign phenotype) on a matrix
conditioned by aggressive melanoma cells (C8161). Figure
3 shows that C8161 cells cultured on a 3-D type I collagen
matrix produce visible networks (delineated by arrows; left
panel) as part of their vasculogenic mimicry phenotype.
After the aggressive cancer cells were removed, human
melanocytes were placed on the conditioned matrix,
inducing these normal cells to form vasculogenic mimic-
ry-like networks. Coincident with the initiation of the more
aggressive phenotype was an induction of VE-Cadherin
expression, suggesting an epigenetic modification consis-
tent with a vascular cell-like molecular profile, similar to
that of the aggressive melanoma phenotype [40]. This result
highlights the powerful influence that certain cell types
have on their microenvironment and in this instance, the bi-
directional communication between normal melanocytes
and a cancerous microenvironment led to the acquisition of
tumor cell-like characteristics.
Melanocytes are not the only cell type susceptible to
this kind of epigenetic modulation by a cancerous micro-
environment. When hESCs are cultured on a 3-D matrix
conditioned by aggressive melanoma cells for 3 days, their
morphologic transformation is striking (Fig. 4a). Rather
than typical spheroidal clusters under control conditions
(top left panel), hESCs begin to flatten on the matrix,
migrate as a monolayer, and exhibit a mesenchymal-like
morphology—characteristics associated with the aggressive
melanoma cells that conditioned this microenvironment.
This dramatic change in cell morphology is associated with
intriguing gene expression changes as well (Fig. 4b).
hESCs cultured on an C8161 CMTX for 3 days and
harvested for mRNA analysis demonstrate: (1) a significant
Fig. 3 Normal melanocytes acquire a vasculogenic-like dedifferentiated
phenotype following exposure to the microenvironment of metastatic
melanoma cells. Phase-contrast microscopy of human melanocytes and
C8161 melanoma cells grown in 3-D matrices of type I collagen. Human
epidermal melanocytes (HEMn) form dense monolayers when cultured
on a 3-D collagen-I matrix (top). In contrast, metastatic melanoma cells
(C8161) form vasculogenic-like networks (arrowheads). HEMn cells
cultured on a matrix conditioned by C8161 cells (C8161 CMTX)a r e
also able to form vasculogenic-like networks. Micron bar equals
200 μm for all micrographs
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stem cell pluripotency and an undifferentiated state (Nodal,
Lefty and Nanog), and (2) dramatic amplification of genes
associated with a differentiated cellular phenotype (Vimentin
and VE-Cadherin). Specifically, Nodal is suppressed to
nearly 20% of control levels, consistent with the morpho-
logic changes noted in Fig. 4a following exposure to an
C8161 CMTX. Lefty, one of Nodal’s inhibitors and
expressed primarily by undifferentiated hESCs, is found at
less than 50% of control levels. Again, this finding is con-
sistent with the notion that hESCs, induced by the cancerous
microenvironment, lose this regulatory factor inherent to
hESCs—and critical to cell fate determination. Furthermore,
Nanog, a marker widely associated with ‘stemness’,i s
decreased in expression following hESC exposure to a
melanoma tumor-conditioned microenvironment.
Conversely, when hESCs are exposed to the C8161
CMTX, two cell phenotype-associated markers are consid-
erably up-regulated compared to hESC controls. Vimentin,
an intermediate filament protein expressed first by cells of
mesodermal origin and a marker of a mesenchymal cell
type, is amplified nearly tenfold. Furthermore, as is observed
following melanocyte exposure to an aggressive melanoma
CMTX, the endothelial-specific marker VE-Cadherin is up-
regulated—in this circumstance almost 300-fold—in hESCs
exposed to a microenvironment conditioned by aggressive
melanoma tumor cells.
Taken together, these compelling data confirm that just
as hESCs have the ability to condition their microenviron-
ment and epigenetically modulate their surroundings,
aggressive melanoma cells can also radically alter and
manipulate their milieu without requiring cell–cell contact
or direct communication. The soluble factors associated
with a conditioned microenvironment may be derived from
a multitude of cell types and signal either pro- or anti-
tumorigenic effects. Using an approach based on our
understanding of how cells confer influential cues via their
extracellularmicroenvironment,noveltherapeuticapproaches
may be designed which specifically target signaling mole-
cules in the tumor microenvironment associated with cancer
progression.
Convergence of Embryonic and Tumorigenic Signaling
Pathways
The embryonic microenvironment, as discussed above, is
by necessity tightly regulated via a number of signaling
pathways, and our research group has focused on the Nodal
signaling axis. Nodal is an embryonic morphogen respon-
sible for left–right patterning in the embryo, maintenance of
pluripotency/self-renewal in human embryonic stem cells and
appears to play a critical role in maintaining the undifferen-
tiated state of cells [20, 41, 42]. While Nodal expression is
lost as hESCs lose their undifferentiated state and undergo
differentiation, it is re-expressed in a dysregulated fashion in
aggressive melanoma and breast cancer cells [2, 43].
The mechanisms of Nodal signaling are complex. Nodal
binds to the ALK 4/5/7 and ActIIRB receptor complex
utilizing Cripto as a co-receptor (member of the EGF-CFC
Fig. 4 hESCs exhibit a vasculogenic and mesenchymal-like pheno-
type following exposure to the microenvironment of metastatic
melanoma cells. a Phase-contrast microscopy of hESCs grown on 3-
D Matrigel matrices. Under control conditions, hESCs grow as
densely packed undifferentiated colonies. In contrast, hESCs cultured
on a matrix conditioned by C8161 cells (C8161 CMTX) exhibit an
altered phenotype reminiscent of cell differentiation. b Real time RT-
PCR analysis of Nodal, Lefty, Nanog, Vimentin, and VE-Cadherin
mRNA in hESCs exposed for 3 days to either control (unconditioned)
Matrigel or to Matrigel conditioned by human metastatic melanoma
cells (C8161 CMTX). Gene levels were normalized using RPLPO and
bars represent mean gene expression±standard deviation normalized to
gene expression in hESCs cultured under control conditions
18 D.E. Abbott, et al.family) to enhance its signal. This activation results in
phosphorylation of ALK 4/5/7, which in turn phosphor-
ylates the Smad 2/3 complex. This p-Smad 2/3 complex
binds Smad 4 which in turn signals nuclear transcription of
Nodal as well as Lefty, its natural inhibitor [44]. Each
ligand binding and signal transduction step also lends
itself to possible therapeutic inhibition by small molecule
inhibitors, immunoregulation and/or directed targeting of
key components of the signaling pathway [43].
It is important to note that Nodal not only regulates itself
via an autocrine, feed-forward mechanism [5], but it is also
secreted where it exerts its effects locally through the
microenvironment. The importance of secreted Nodal has
been demonstrated in studies during which Nodal has been
experimentally inhibited in a zebrafish embryo model.
Nodal, when either ectopically injected or secreted by cancer
cells transplanted into the embryo, induced secondary axis
formationandectopiccranial outgrowthsinthezebrafish[5].
However, when Nodal is antagonized by either over-
expression of Lefty-1 in the zebrafish microenvironment
[45, 46] or morpholino treatment (Nodal
MO in the cancer
cells), ectopic axes and outgrowths are significantly reduced
[5]. While these studies are compelling with respect to
embryologic development, cell-fate determination and
growth, the influence of Nodal secretion in cancer must still
be elucidated.
Given the effects of Nodal and the Nodal signaling
cascade in these model systems, we examined potential
changes in Nodal expression in aggressive melanoma
cells following exposure to an hESC CMTX. As shown
by protein analysis in Fig. 5a, Nodal is highly expressed by
both hESCs and aggressive melanoma cells (C8161).
However, when melanoma cells are exposed to an hESC
CMTX, Nodal mRNA expression is significantly down-
regulated by nearly 80% compared with control levels
(Fig. 5b) and remains suppressed for several days after
Fig. 5 Exposure to an hESC microenvironment decreases the
expression of a potent embryonic-associated morphogen (Nodal)
aberrantly expressed in aggressive melanoma cells. a Western blot
analysis of Nodal in hESCs and in C8161 human metastatic
melanoma cells. Actin is used as a loading control. b Real time RT-
PCR analysis of Nodal mRNA in C8161 melanoma cells exposed for
3 days to either fresh Matrigel (control) or to Matrigel conditioned by
hESCs (hESCs CMTX). Some cancer cells exposed to the CMTX were
subsequently recovered on control (unconditioned) Matrigel for 2 or
7 days prior to analysis. Gene levels were normalized using 18s and
bars represent mean gene expression normalized to Matrigel control
Fig. 6 Down-regulation of Nodal expression by exposure to the
hESC microenvironment or by knock down with Nodal morpholino
leads to abrogation metastatic melanoma tumorigenicity. a The ratio of
tumor cell proliferation to apoptosis in tumors derived from human
metastatic melanoma cells (C8161), determined by immunohisto-
chemical staining for Ki-67 and terminal deoxynucleotidyl transferase
biotin-dUTP nick-end labeling (TUNEL). Prior to injection into a
mouse, C8161 cells were cultured for 3 days on control or hESC
conditioned matrices (hESC CMTX), or treated with MO Nodal to
knock down Nodal expression. Bars represent mean normalized
values±standard deviation, and values indicated by an asterisk are
significantly different from control values (p<0.05). b In vivo tumor
formation in mice injected with Nodal morpholino-transfected C8161
cells (MO Nodal) vs. melanoma cells transfected with control
morpholino (MO Control), introduced orthotopically subcutaneously.
Values represent the median tumor volume (mm
3)±interquartile range
(n=5/group, p<0.05)
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and grown on a control matrix. However, after 7 days of
recovery the Nodal mRNA levels return to near control
levels in the melanoma cells. This inhibition of Nodal by a
microenvironment conditioned by hESCs suggests a poten-
tial therapeutic target based on an anti-Nodal treatment
regime that merits further scientific investigation.
Since Nodal is expressed and secreted in a dysregulated
fashion by aggressive melanoma cells which do not express
Lefty (an endogenous Nodal inhibitor, as shown in Table 1),
a direct assumption would be that targeted disruption of
Nodal could have significant effects on tumor cell growth.
This was shown to be the case when Nodal morpholino
treatment (morpholine ring-based anti-sense nucleotides) of
C8161 cells was found to decrease the proliferation/
apoptosis ratio of the cells by nearly 80% compared to
controls (Fig. 6a). A similar effect was seen when the
C8161 cells were cultured on an hESC CMTX, and might
be attributed to the deposition of inhibitors of Nodal, such
as Lefty, into the hESC CMTX. These in vitro data are
supported by in vivo experiments which demonstrate and
confirm the effects of Nodal inhibition on tumor growth [5].
C8161 melanoma cells treated with Nodal morpholino and
harvested for xenograft transplantation in the subcutaneous
tissue of nude mice exhibit significantly less tumor forma-
tion and growth than cells treated with control morpholinos
(Fig. 6b). More than 2 weeks following implantation, tumor
volume in treated C8161 xenografts remained less than
20% of controls. After 2 weeks, Nodal is re-expressed in
the melanoma xenografts and tumorigenicity resumes. This
intriguing finding suggests that targeted and sustained
therapy against a key developmental factor, such as Nodal,
may represent a new therapeutic approach to treating
cancer.
Conclusion
Clearly, the embryonic microenvironment (such as the one
associated with hESCs) is remarkable in its capacity to
foster exquisitely complex developmental and regulatory
processes in both time and space, ultimately supporting
normal cellular differentiation. Here, we demonstrate the
epigenetic influence of the hESC microenvironment on the
reprogramming of aggressive melanoma cells using an
innovative 3-D model. Specifically, our laboratory has
previously demonstrated the redifferentiation of these
melanoma cells to a more melanocyte-like phenotype [1],
and now we show the loss of VE-Cadherin expression
(indicative of a plastic vasculogenic phenotype) and the
loss of Nodal expression (a plasticity stem cell marker) in
tumor cells exposed to the hESC microenvironment.
Although quite intriguing, this reprogramming event
appears to be transient, as melanoma cells revert back to
their original plastic phenotype 1 week after removal from
the hESC microenvironment. Further studies with the 3-D
culture model revealed the epigenetic influence of aggres-
sive melanoma cells on hESCs resulting in the down-
regulation of plasticity markers and the emergence of
phenotype-specific genes. Additional studies with the
aggressive melanoma conditioned matrix microenviron-
ment demonstrated the transdifferentiation of normal
melanocytes into melanoma-like cells exhibiting a vasculo-
genic phenotype. Collectively, these studies have advanced
our understanding of the epigenetic influence associated
with the microenvironments of hESCs and aggressive
melanoma cells, and shed new light on their therapeutic
implications. Moreover, we have a better appreciation of
the convergence of embryonic and tumorigenic signaling
pathways that might stimulate further consideration of
targeting Nodal in aggressive tumor cells resulting in a
down-regulation of tumorigenic potential and plasticity.
Therapeutic strategies will continue to target tumor cells
themselves, but we must not neglect the impact that tumor
cells have on their surrounding cellular and stromal
components. As discovery proceeds, we may recognize
that antagonizing tumor/microenvironment signaling is a
crucial component of any effective therapy, disallowing
aggressive tumor cells to manipulate their surroundings to
facilitate their progression. The novel nature of these
advances should only improve as our understanding
becomes more sophisticated.
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